29.10.2004 |
LT |
Europos Sąjungos oficialusis leidinys |
C 266/5 |
Bendrijos sprendimų dėl leidimų prekiauti vaistais sąrašas nuo 2004 m. rugsėjo 15 d. iki 2004 m. spalio 15 d.
(paskelbta sutinkamai su Tarybos Reglamento (EEB) Nr. 2309/93 (1) 12 arba 34 straipsniu)
(2004/C 266/04)
Leidimo prekiauti išdavimas (Tarybos Reglamento (EEB) Nr. 2309/93 12 straipsnis), leidimas išduotas
Sprendimo data |
Vaisto pavadinimas |
Leidimo savininkas |
Įrašo Bendrijos registre nr. |
Pranešimo data |
2004 9 20 |
Angiox |
The Medicines Company UK Ltd, Suite B, Park House, 11 Milton Park, Abingdon, Oxfordshire OX14 4RS, United Kingdom |
EU/1/04/289/001 |
2004 9 22 |
2004 9 20 |
Alimta |
Eli Lilly Nederland B.V., Grootslag 1-5, 3991 RA Houten, Nederland |
EU/1/04/290/001 |
2004 9 22 |
2004 9 20 |
Raptiva |
Serono Europe Limited, 56, Marsh Wall, London E14 9TP, United Kingdom |
EU/1/04/291/001-002 |
2004 9 22 |
2004 9 21 |
Protelos |
Les Laboratoires Servier, 22, rue Garnier, F-92200 Neuilly sur-Seine, France. |
EU/1/04/288/001-006 |
2004 9 23 |
2004 9 21 |
Osseor |
Les Laboratoires Servier, 22, rue Garnier, F-92200 Neuilly sur-Seine, France |
EU/1/04/287/001-006 |
2004 9 23 |
2004 9 27 |
Apidra |
Aventis Pharma Deutschland GmbH, Brueningstrasse 50, D-65926 Frankfurt am Main, Deutschland |
EU/1/04/285/001-020 |
2004 9 29 |
2004 10 13 |
Wilzin |
Orphan Europe SARL, Immeuble „Le Guillaumet“F-92046 Paris-La-Défense - France |
EU/1/04/286/001-002 |
2004 10 18 |
Leidimo prekiauti pakeitimas (Tarybos Reglamento (EEB) Nr. 2309/93 12 straipsnis), leidimas pakeistas
Sprendimo data |
Vaisto pavadinimas |
Leidimo savininkas |
Įrašo Bendrijos registre nr. |
Pranešimo data |
2004 9 20 |
Remicade |
Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland |
EU/1/99/116/001-003 |
2004 9 22 |
2004 9 20 |
Azomyr |
Schering Plough Europe, Rue de Stalle 73, B-1180 Bruxelles, Belgique |
EU/1/00/157/014-021 |
2004 9 22 |
2004 9 20 |
Aerius |
Schering Plough Europe, Rue de Stalle 73, B-1180 Bruxelles, Belgique |
EU/1/00/160/014-021 |
2004 9 22 |
2004 9 20 |
Neoclarityn |
Schering Plough Europe, Rue de Stalle 73, B-1180 Bruxelles, Belgique |
EU/1/00/161/014-021 |
2004 9 22 |
2004 9 20 |
Lantus |
Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main, Deutschland |
EU/1/00/134/008-011 EU/1/00/134/018-021 |
2004 9 22 |
2004 9 20 |
Velcade |
Millennium Pharmaceuticals, Ltd, Building 3, Chiswick Park, 566 Chiswick High Road, Chiswick, London, W4 5YA United Kingdom |
EU/1/04/274/001 |
2004 9 22 |
2004 9 20 |
Velcade |
Janssen-Cilag International NV, Turnhoutsewe 30, B-2340 Beerse, België |
EU/1/04/274/001 |
2004 9 23 |
2004 9 20 |
Ovitrelle |
Serono Europe Limited, 56, Marsh Wall, London E14 9TP, United Kingdom |
EU/1/00/165/001-007 |
2004 9 22 |
2004 9 21 |
Carbaglu |
Orphan Europe, Immeuble „Le Guillaumet“, F-92046 Paris La Défense, France |
EU/1/02/246/001-002 |
2004 9 23 |
2004 9 21 |
KOGENATE Bayer |
Bayer AG, D-51368 Leverkusen, Deutschland |
EU/1/00/143/004-006 |
2004 9 23 |
2004 9 23 |
Remicade |
Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland |
EU/1/99/116/001-003 |
2004 9 27 |
2004 9 24 |
Insuman |
Aventis Pharma Deutschland GmbH, Brueningstrasse 50, D-65926 Frankfurt am Main, Deutschland |
EU/1/97/030/065-084 |
2004 9 29 |
2004 9 24 |
InductOs |
Wyeth Europa Ltd., Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom |
EU/1/02/226/001 |
2004 9 28 |
2004 9 24 |
Enbrel |
Wyeth Europa Limited, Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom |
EU/1/99/126/001-003 |
2004 9 28 |
2004 9 27 |
SonoVue |
Bracco International B.V., Strawinskylaan 3051, 1077ZX Amsterdam, Nederland |
EU/1/01/177/001-002 |
2004 9 29 |
2004 9 27 |
Ceprotin |
Baxter AG, Industriesstrasse 67, A-1220 Vienna, Österreich |
EU/1/01/190/001-002 |
2004 9 29 |
2004 9 27 |
Avonex |
Biogen Idec France, „Le Capitole“ 55, avenue des Champs Pierreux, F-92012 Nanterre Cedex - France. |
EU/1/97/033/001-003 |
2004 9 30 |
2004 10 13 |
Revasc |
Canyon Pharmaceuticals Ltd, 20-22 Bedford Row - WC1R 4JS London - United Kingdom |
EU/1/97/043/001-002 |
2004 10 19 |
Aventis Pharma S.A., 20 Avenue Raymond Aron, Antony Cedex F-92165, France |
2004 10 18 |
|||
2004 10 13 |
Arava |
Aventis Pharma Deutschland GmbH, D-65926 Frankfurt am Main, Deutschland |
EU/1/99/118/001-010 |
2004 10 18 |
2004 10 13 |
Vaniqa |
Shire Pharmaceutical Contracts Ltd, Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, United Kingdom |
EU/1/01/173/001-003 |
2004 10 18 |
2004 10 13 |
NovoRapid |
Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark |
EU/1/99/119/001-014 |
2004 10 18 |
2004 10 13 |
Levviax |
Aventis Pharma S.A., 20 Avenue Raymond Aron, F-92160 Antony, France |
EU/1/01/192/001-005 |
2004 10 19 |
2004 10 15 |
Ketek |
Aventis Pharma S.A., 20 Avenue Raymond Aron, F-92160 Antony, France |
EU/1/01/191/001-005 |
2004 10 19 |
2004 10 15 |
Viramune |
Boehringer Ingelheim International GmbH, Binger Strasse 173, D-55216 Ingelheim am Rhein, Deutschland |
EU/1/97/055/001-002 |
2004 10 19 |
2004 10 15 |
Fuzeon |
Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom |
EU/1/03/252/001-003 |
2004 10 20 |
2004 10 15 |
NovoRapid |
Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danmark |
EU/1/99/119/001 EU/1/99/119/003 EU/1/99/119/005-014 |
2004 10 19 |
Leidimo prekiauti panaikinimas (Tarybos Reglamento (EEB) Nr. 2309/93 12 straipsnis)
Sprendimo data |
Vaisto pavadinimas |
Leidimo savininkas |
Įrašo Bendrijos registre nr. |
Pranešimo data |
2004 9 28 |
Ixense |
Takeda Europe R&D Centre Ltd, Savanah House, 11/12 Charles II Street, London SW1Y 4QU, United Kingdom |
EU/1/01/181/001-007 |
2004 9 30 |
(1) OL L 214, 1993 8 24, p. 1.